| 1 |
Khan SR, Pearle MS, Robertson WG, et al. Kidney stones [J]. Nat Rev Dis Primers, 2016, 2: 16008.
|
| 2 |
Wiener SV, Ho SP, Stoller ML. Beginnings of nephrolithiasis: insights into the past, present and future of Randall's plaque formation research [J]. Curr Opin Nephrol Hypertens, 2018, 27(4): 236-242.
|
| 3 |
李永超, 李杨. 肾结石Randall斑块研究进展 [J]. 中南大学学报(医学版), 2020, 45(4): 435-439.
|
| 4 |
Zeng G, Mai Z, Xia S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study [J]. BJU Int, 2017, 120(1): 109-116.
|
| 5 |
Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors [J]. Rev Urol, 2010, 12(2-3): e86-96.
|
| 6 |
Ping H, Lu N, Wang M, et al. New-onset metabolic risk factors and the incidence of kidney stones: a prospective cohort study [J]. BJU Int, 2019, 124(6): 1028-1033.
|
| 7 |
Kittanamongkolchai W, Mara KC, Mehta RA, et al. Risk of hypertension among first-time symptomatic kidney stone formers [J]. Clin J Am Soc Nephrol, 2017, 12(3): 476-482.
|
| 8 |
Shang W, Li Y, Ren Y, et al. Nephrolithiasis and risk of hypertension: a meta-analysis of observational studies [J]. BMC Nephrol, 2017, 18(1):344.
|
| 9 |
Eisner BH, Porten SP, Bechis SK, et al. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis [J]. J Urol, 2010, 183(2): 576-579.
|
| 10 |
靳潇潇, 何文强. 含钙肾结石与骨密度之间关系的研究现状 [J]. 中国骨质疏松杂志, 2021, 27(2): 303-307.
|
| 11 |
Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria [J]. N Engl J Med, 2002, 346(2): 77-84.
|
| 12 |
Nouvenne A, Meschi T, Prati B, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial [J]. Am J Clin Nutr, 2010, 91(3): 565-570.
|
| 13 |
Hartman C, Friedlander JI, Moreira DM, et al. Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis? [J]. Urology, 2015, 85(3): 539-543.
|
| 14 |
Kohjimoto Y, Sasaki Y, Iguchi M, et al. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan [J]. Am J Kidney Dis, 2013, 61(6): 923-929.
|
| 15 |
Liu YT, Yang PY, Yang YW, et al. The association of nephrolithiasis with metabolic syndrome and its components: a cross-sectional analysis [J]. Ther Clin Risk Manag, 2017, 13: 41-48.
|
| 16 |
Zafar U, Khaliq S, Ahmad HU, et al. Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links [J]. Hormones, 2018, 17(3): 299-313.
|
| 17 |
Brown A E, Walker M. Genetics of insulin resistance and the metabolic syndrome [J]. Curr Cardiol Rep, 2016, 18(8): 75.
|
| 18 |
Strohmaier WL, Wrobel BM, Schubert G. Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis [J]. Urol Res, 2012, 40(2): 171-175.
|
| 19 |
Evan AP, Worcester EM, Coe FL, et al. Mechanisms of human kidney stone formation [J]. Urolithiasis, 2015, 43 Suppl 1(0 1):19-32.
|
| 20 |
Esteghamat F, Broughton JS, Smith E, et al. CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation [J]. Nat Genet, 2019, 51(8): 1233-1243.
|
| 21 |
Khan SR, Canales BK, Dominguez-Gutierrez PR. Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation [J]. Nat Rev Nephrol, 2021, 17(6): 417-433.
|
| 22 |
Yang H, Xie T, Li D, et al. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway [J]. Mol Metab, 2019, 23: 24-36.
|
| 23 |
Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy [J]. J Hepatol, 2016, 64(6): 1403-1415.
|
| 24 |
Zhang X, Fan L, Wu J, et al. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization [J]. J Hepatol, 2019, 71(1): 163-174.
|
| 25 |
Org E, Blum Y, Kasela S, et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort [J]. Genome Biol, 2017, 18(1): 70.
|
| 26 |
Ma MC, Chen YS, Huang HS. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage [J]. Urology, 2014, 83(2): 510 e9-17.
|
| 27 |
Joshi S, Khan SR. Opportunities for future therapeutic interventions for hyperoxaluria: targeting oxidative stress [J]. Expert Opin Ther Targets, 2019, 23(5): 379-391.
|
| 28 |
叶涛, 叶章群. 炎症和氧化应激反应与肾结石形成的研究进展 [J]. 中华泌尿外科杂志, 2018, 39(9): 711-713.
|
| 29 |
Wang Y, Sun C, Li C, et al. Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines [J]. Urolithiasis, 2017, 45(2): 159-175.
|
| 30 |
Fukumoto J, Fukumoto I, Parthasarathy PT, et al. NLRP3 deletion protects from hyperoxia-induced acute lung injury [J]. Am J Physiol Cell Physiol, 2013, 305(2): C182-C189.
|
| 31 |
Mulay S R, Kulkarni O P, Rupanagudi K V, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion [J]. J Clin Invest, 2013, 123(1): 236-246.
|
| 32 |
Umekawa T, Hatanaka Y, Kurita T, et al. Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys [J]. J Am Soc Nephrol, 2004, 15(3): 635-644.
|
| 33 |
Dominguez-Gutierrez PR, Kusmartsev S, Canales BK, et al. Calcium oxalate differentiates human monocytes into inflammatory M1 macrophages [J]. Front Immunol, 2018, 9: 1863.
|
| 34 |
Liu Q, Liu Y, Guan X, et al. Effect of M2 macrophages on injury and apoptosis of renal tubular epithelial cells induced by calcium oxalate crystals [J]. Kidney Blood Press Res, 2019, 44(4): 777-791.
|
| 35 |
Small H Y, Migliarino S, Czesnikiewicz-Guzik M, et al. Hypertension: focus on autoimmunity and oxidative stress [J]. Free Radic Biol Med, 2018, 125: 104-115.
|
| 36 |
Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? [J]. Am J Physiol Regul Integr Comp Physiol, 2005, 289(4): R913-R935.
|
| 37 |
Montezano AC, Dulak-Lis M, Tsiropoulou S, et al. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies [J]. Can J Cardiol, 2015, 31(5): 631-641.
|
| 38 |
陈颖妹, 马建林. 同型半胱氨酸、氧化应激与高血压关系的研究进展 [J]. 中国循证心血管医学杂志, 2020, 12(7): 895-896.
|
| 39 |
Rudemiller NP, Crowley SD. Interactions between the immune and the renin-angiotensin systems in hypertension [J]. Hypertension, 2016, 68(2): 289-296.
|
| 40 |
Justin Rucker A, Crowley SD. The role of macrophages in hypertension and its complications [J]. Pflugers Arch, 2017, 469(3-4): 419-430.
|
| 41 |
Chien TM, Lu YM, Chou YH, et al. Percutaneous nephrolithotomy increases the risk of new-onset hypertension: a nationwide 6-year follow-up study [J]. Urology, 2016, 97: 61-65.
|
| 42 |
Lu YM, Chien TM, Chou YH, et al. Is extracorporeal shock wave lithotripsy really safe in long-term follow-up? a nationwide retrospective 6-year age-matched non-randomized study [J]. Urol Int, 2017, 98(4): 397-402.
|
| 43 |
Ng CF, Luke S, Yee CH, et al. Extracorporeal shockwave lithotripsy could lead to a prolonged increase in the renal fibrotic process of up to 2 years [J]. J Endourol, 2018, 32(3): 223-229.
|
| 44 |
Fankhauser CD, Kranzbühler B, Poyet C, et al. Long-term adverse effects of extracorporeal shock-wave lithotripsy for nephrolithiasis and ureterolithiasis: a systematic review [J]. Urology, 2015, 85(5): 991-1006.
|
| 45 |
Qin B, Wang Q, Lu Y, et al. Losartan ameliorates calcium oxalate-induced elevation of stone-related proteins in renal tubular cells by Inhibiting NADPH oxidase and oxidative stress [J]. Oxid Med Cell Longev, 2018: 1271864.
|
| 46 |
Zhu J, Wang Q, Li C, et al. Inhibiting inflammation and modulating oxidative stress in oxalate-induced nephrolithiasis with the Nrf2 activator dimethyl fumarate [J]. Free Radic Biol Med, 2019, 134: 9-22.
|
| 47 |
庞翀, 陈群娟. 缬沙坦联合富马酸比索洛尔对老年高血压心脏病患者相关生化指标、炎症因子及氧化应激水平的影响 [J]. 中国老年学杂志, 2021, 41(4): 673-676.
|
| 48 |
Alexander RT, Mcarthur E, Jandoc R, et al. Antihypertensive medications and the risk of kidney stones in older adults: a retrospective cohort study [J]. Hypertens Res, 2017, 40(9): 837-842.
|